HCPCS Level IIdrugActive
J1308
Inj, famotidine, 0.25 mg
BETOS: O1E
Effective: 2025-04-01
Description
Injection, famotidine, 0.25 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Famotidine
Manufacturer
Baxter Healthcare Corporation
HCPCS Dosage
0.25 MG
Billing Units
80.0000
15
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.